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SUMMARY
HIV/AIDS-associated visceral leishmaniasis may display the characteristics of an aggressive disease or without specific symptoms 
at all, thus making diagnosis difficult. The present study describes the results of diagnostic tests applied to a series of suspected VL 
cases in HIV-infected/AIDS patients admitted in referral hospitals in Pernambuco, Brazil. From a total of 14 eligible patients with 
cytopenias and/or fever of an unknown etiology, and indication of bone marrow aspirate, 10 patients were selected for inclusion in the 
study. Diagnosis was confirmed by the following examinations: Leishmania detection in bone marrow aspirate, direct agglutination test, 
indirect immunofluorescence, rK39 dipstick test, polymerase chain reaction and latex agglutination test. Five out of the ten patients 
were diagnosed with co-infection. A positive direct agglutination test was recorded for all five co-infected patients, the Leishmania 
detection and latex agglutination tests were positive in four patients, the rK39 dipstick test in three, the indirect immunofluorescence in 
two and a positive polymerase chain reaction was recorded for one patient. This series of cases was the first to be conducted in Brazil 
using this set of tests in order to detect co-infection. However, no consensus has thus far been reached regarding the most appropriate 
examination for the screening and monitoring of this group of patients.
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INTRODUCTION
In HIV-infected patients, visceral leishmaniasis (VL) accelerates the 
onset of AIDS and the disease can progress rapidly into severe forms22,24. 
HIV-VL co-infection may appear clinically in its classical form or with 
very aggressive characteristics, sometimes non-specific and difficult to 
diagnose29.
The association between the diseases is recent and has an increasing 
number of cases in Brazil and worldwide - especially in the Mediterranean 
region of Europe15,18. In Brazil, a phenomenon of overlapping infections 
characterized by the ruralization of AIDS and urbanization of VL has 
been observed, which indicates the emergence of parasitic disease as an 
important infection opportunistic to HIVpatients11. However, there are 
very few reports from Brazil concerning co-infection6,10,17,25.
The present study describes the results of diagnostic tests applied to 
a series of suspected VL cases in HIV-infected/AIDS patients.
PATIENTS AND METHODS
HIV-infected/AIDS patients were included in the study after they 
were admitted to four public hospitals in Pernambuco, Brazil, between 
September 2008 and January 2010. The study included 18-year-old 
patients, who presented cytopenia (leucocyte count < 3,000/mm3, 
hemoglobin concentration < 10 g/dL, platelet count <120,000/mm3) in 
at least two cell lines and/or fever (> 38 °C) for more than eight days, 
with no defined etiology and indication of bone marrow aspirate from 
the doctor’s assistant. The study was approved by the Research Ethics 
Committee at the Aggeu Magalhães Research Center - Fundação Oswaldo 
Cruz (CAAE 0121.0.095.000-08).
HIV diagnosis was confirmed by Western blot or indirect 
immunofluorescence7 and VL by identifying amastigotes in bone marrow 
aspirates and/or positive results in KAtex12, with good therapeutic 
responses.
Evidence for a favorable response to therapy (clinical remission) 
was considered when the patient was afebrile and when physical signs as 
well as laboratory abnormalities significantly improved after a complete 
course of treatment1. 
The direct agglutination test (DAT) was used to detect anti-
Leishmania antibodies. A result was considered positive when ≥ 1/6,40021. 
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The reaction to indirect immunofluorescence (IFA) was considered 
positive when fluorescence was observed in a dilution of ≥ 1/8018 and 
the rK39 dipstick test was considered positive when two lines were 
visualized on the strip9.
For the polymerase chain reaction in peripheral blood (PCR - 
illustra TM tissue & cells genomicPrep Mini Spin KIT), RV1 and RV2 
primers were used15. DNA bands were separated by electrophoresis and 
visualized under a UV light, and photographed with the Kodak Gel Logic 
100 Imaging System, using Kodak molecular imaging software 4.0.0. 
The latex agglutination test (Katex - Kalon Biological Ltd’s, UK) was 
categorized as: positive +++, and ++, and +, and negative5. 
RESULTS
Of the 14 eligible patients, two died before undergoing the bone 
marrow aspirate and two were excluded due to the existence of other 
diagnoses (tuberculosis and lymphoma). Nine patients were previously 
diagnosed as having AIDS and other case was diagnosed with AIDS 
during a screening of VL. 
The mean age was 36.1 years (27-44 years/±5.8). Five patients 
had attended school for 11 or more years and five owned a dog. All 
ten patients presented splenomegaly, weight loss and asthenia and one 
reported no fever. 
Nine patients were male and came from the metropolitan region of 
Recife, of which eight were from the urban area and one from the rural 
area (Table 1).
Five co-infected cases were identified from amongst ten who were 
included in the study. Among the five cases of co-infection, there were 
two cases of VL (first episode) and three cases of relapse. Four patients 
tested positive for Leishmania in the bone marrow aspirate. A positive 
PCR was recorded for only one of these patients and nine patients 
obtained a positive DAT. Patient number 6 began a therapeutic test with 
amphotericin B prior to completing the examination for Leishmania in 
bone marrow aspirate, and tested negative, although the KAtex (++) and 
DAT (1/12,800) were positive. A clinical improvement was observed 
with the therapeutic test: hematological counts were normalized and 
splenomegaly and fever reduced. Of the ten HIV-infected patients, nine 
(five with VL and four without VL) had a positive serologic test (DAT). 
The mean age of the five co-infected patients was 37.2 (31-44 
years/± 6.0). Four were male, from the metropolitan region of Recife, 
and the only female patient was from the rural area. The female patient 
of this series was an agricultural worker, living in the agricultural zone 
of Pernambuco, and reported cases of VL at home (partner) and around 
the local neighborhood. Two of the male patients maintained sexual 
relations with other men and the female was in a stable relationship with 
her HIV-infected partner. None of the patients reported intravenous drug 
Table 1
Results of specific tests in the ten HIV-infected/AIDS patients tested for visceral leishmaniasis during the period from September 2008 to January 2010 in four 
hospitals of Pernambuco, Brazil
Patient From Sex Bone marrow 
aspirate
DAT rK39 IFA KAtex PCR HIV/VL 
co-infection
1 Recife 
(Urban)
Male negative 1/400 
negative
negative negative negative negative negative
2 Cabo Sto 
Agostinho (Urban)
Male negative 1/6400 
positive
negative negative negative negative negative
3 Itamaracá 
(Urban)
Male negative 1/6400 
positive
negative negative negative negative negative
4 Cabo Sto 
Agostinho (Urban)
Male negative 1/25600 
positive
negative negative negative negative negative
5 Moreno 
(Urban) 
Male negative >1/51200 
positive
negative negative negative negative negative
6 Recife 
(Urban)
Male negative 1/12800 
positive
negative negative ++ 
positive
negative 1st episode
7 Igarassu 
(Urban)
Male positive >1/51200 
positive
negative negative ++ 
positive
negative 1st episode
8 Recife 
(Urban)
Male positive >1/51200 
positive
positive negative NM* negative Relapse 
(2nd episode)
9 Glória de Goitá 
(Urban)
Female positive 1/1638400 
positive
positive 1/80 
positive
+++ 
positive
negative Relapse 
(2nd episode)
10 Igarassu 
(rural)
Male positive 1/25600 
positive
positive 1/80 
positive
+++ 
positive
positive Relapse 
(3rd episode)
NM*: Examination not made.
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use. Two of these patients had attended school for more than 11 years 
and also owned dogs.
A positive DAT was recorded in all co-infected patients (1/12,800 - 
1/1,638,400). Four patients presented a positive KAtex test (++/+++), and 
one did not perform the examination. Three patients recorded a positive 
rK39 dipstick test; two a positive IFA (1/80) and one patient presented 
a positive PCR (Table 1).
The mean CD4 count was 208 cells/mm3 (56-399/+153). Four 
patients were taking antiretrovirals (ART) and one was diagnosed with 
VL concomitantly with AIDS. The five patients diagnosed as co-infected 
were treated with amphotericin B. Three of the five cases diagnosed in the 
study reported previous episodes of co-infection, two of them relapsed 
in less than one year after treatment and did not receive prophylaxis, 
the other relapsed two years after discontinuation of prophylaxis with 
amphotericin B.
DISCUSSION
Five co-infected cases were identified from amongst ten who 
presented clinical indications of bone marrow aspirate, signs and 
symptoms compatible with classical forms of VL. The symptoms 
presented by the co-infected patients in this series may occur in other 
situations associated with AIDS, which can hinder or delay a clinical 
suspicion of VL10,22.
All patients had splenomegaly. Febrile splenomegaly and cytopenia 
in HIV-infected patients may also be observed in tuberculosis26, 
histoplasmosis8 and lymphoma23. Cytopenias are frequent during the 
course of HIV infection and may result from several mechanisms24. In 
addition, is important to be alert for possible situations of co-infection 
where manifestations of VL are atypically presented28.
In this series, one of the five co-infected patients was diagnosed 
with VL concomitantly with AIDS. Visceral leishmaniasis may be the 
first infection related in 13% up to 47% of HIV-infected patients22,24. It 
is important to make an early diagnosis and monitor the development 
of leishmaniasis in HIV-infected patients, since these cases are less 
responsive to treatment and have higher fatality rates30. 
All patients with previous episodes of VL had taken ART. In 2008, 
TER HORST, et al.32, reported a reduction in the occurrence of new 
episodes with the use of ART. MIRA et al. 19, however, concluded that 
if the patients had a high viral load and a low immune response, ART 
proved ineffective in preventing new episodes of the disease. 
Microscopic observation of bone marrow aspirate is very specific 
(100%), but sensitivity has been reported between 67% and 94%9,24. 
Several reasons have been cited for the limited sensitivity: a low number 
of Leishmania-infected cells as a consequence of pancytopenia; a 
hemodiluted sample due to inadequate collection or a low parasite load 
when the patient has already started therapy20,30. Patient six tested negative 
for Leishmania, but presented positive results with DAT and KAtex. 
This case was considered co-infection and showed a good therapeutic 
response. 
Urinary antigen detection (KAtex test) was able to positively 
diagnose all cases of infection even after initiating amphotericin B. 
However, it has been reported that antigenuria becomes negative after 
successful chemotherapy, suggesting that KAtex may be a useful tool 
for monitoring the efficacy of the treatment2. In another two studies of 
co-infected patients in Spain, KAtex had a sensitivity of 85.7% and 
100%, respectively, when the parasite load was high27,34. ATTAR et al.,5 
reported the potential use of this test to diagnose active infection, although 
the need still exists for additional studies in order to provide a better 
definition of the role of KAtex, both in investigating the infection and 
during post-therapy follow-up. The present report of the use of KAtex in 
co-infected patients is the first publication on the Brazilian population. 
Whether the test is applicable to detecting asymptomatic or subclinical 
populations has still not been sufficiently clarified5,13,27. 
The rK39 dipstick test confirmed the myelogram in all cases of 
recurrence, and no false-positive results were observed. In a study by 
SUNDAR et al. 31, in India, the rK39 dipstick format has proved 100% 
sensitive and 98% specific when compared to splenic aspirates. Another 
validation study, conducted in a tertiary care hospital in southeastern 
Nepal, compared DAT with the rK39 dipstick test on 184 patients with a 
clinical suspicion of VL, and found a sensitivity of 97% and a specificity 
of 71% for the rK39 dipstick test9. The ease of use of the rK39 dipstick 
test and its low cost enable early diagnosis of VL in decentralized settings 
thereby improves access to early life-saving treatment33. 
ASSIS et al.4, reporting in VL sensitivities and specificities of the 
DAT were 90% and 96%, respectively. The authors concluded that DAT 
constituted a useful test and can replace IFAT as the routine diagnostic 
test used by the Brazilian Leishmaniasis Control Program. There is no 
consensus regarding the ideal cutoff point for co-infected patients. A 
positive DAT was recorded for all co-infected patients, but four out of 
the five patients not considered co-infected with VL also tested positive. 
The lowest titer amongst co-infected patients was 1/12,800 (patient 7) and 
the highest was 1/1,638,400 (patient 10). Two of the patients considered 
without VL had borderline titers (1/6,400) and the other two obtained high 
titers for DAT (1/25,600 and 1/> 51,200). One of them was diagnosed 
with a liver abscess and the other a pulmonary abscess. DAT, despite 
being one of the cheapest, simplest and most sensitive for diagnosing 
VL14, does not differentiate between past and recent infections35. The 
DAT test was not a diagnost criterion for co-infection study. This finding 
may be explained by a high prevalence of VL in the area. Due to the 
low sensitivity of bone marrow aspirate (67-94%),9,24 it is possible that 
patients with positive serology and negative aspirate actually had VL. 
The use of KAtex can, however, increase the sensitivity for the diagnosis 
of active disease12,13.
Regarding serologic findings in this study, the functional impairment 
of cell-mediated immunity due to HIV infection may result in the absence 
of an antibody response to Leishmania infection, even when that is 
parasitemia. This impairment of the immune system may explain the 
higher frequency of false-negative antibody tests results in co-infected 
patients29. CHAPPUIS et al.,9 suggest that patients who test positive 
with rK39 dipstick test or present elevated DAT titers, with a history of 
leishmaniasis, should be submitted to a Leishmania test by bone marrow 
or spleen aspirate in order to investigate co-infection. 
No significant anti-Leishmania antibody titers were detected by 
immunofluorescence, and only two of the five cases tested positive. The 
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results of the present study are similar to studies that have described 
low titers for IFA in diagnosing co-infections24,29. The three cases with a 
new episode of co-infection presented positive results for rK39 dipstick 
test as well as DAT.
The PCR used was positive in only one of the five patients. The 
technique and the primers used in the PCR of this series are available 
within the leishmaniasis service in Pernambuco, although, there are no 
studies that validate them for co-infected HIV patients. A Brazilian study 
in 2006 11 using the same primers for PCR in the total blood of dogs, 
encountered a low sensitivity in this method and suggested the possibility 
of treating the low parasite load in the blood. The method used for DNA 
extraction, however, can have influenced the sensitivity and specificity 
of the PCR technique3. 
This is the first study conducted in Brazil to investigate HIV-VL 
co-infection that describes the results of a set of diagnostic tools 
(parasitological, serological, molecular and urinary antigen detection). 
Only 14 patients were eligible for the study in more than one year. This 
low number of patients may be explained by the inclusion criteria based 
on the indication of bone marrow aspirate from the doctor´s assistant. 
This series has included only five patients with co-infection and it is 
difficult therefore to analyze the results of the different diagnostic tests. In 
addition, there were cases of relapse, making even more difficult to reach 
reliable conclusions. Despite the small size of the sample, this article is 
a valuable addition to the limited literature on a topic that is of growing 
importance, both in Brazil and in other VL-endemic areas of the world.
From the clinical symptoms of the suspected or confirmed patients 
it was possible to observe that there are still difficulties in screening and 
diagnosing this particular group of patients. Thus, it may be perceived 
that there are limitations in these diagnostic methods and further studies 
may indicate which examinations are most appropriate for diagnosing 
and monitoring patients with HIV-VL co-infection.
RESUMO
Diagnosticando co-infecção leishmaniose visceral e HIV/AIDS: 
uma série de casos em Pernambuco, Brasil.
A associação da leishmaniose visceral com o HIV/AIDS pode se 
manifestar com características de doença agressiva ou sem sintomas 
específicos, dificultando o diagnóstico. Este artigo descreve o resultado 
de testes diagnósticos aplicados a uma série de casos suspeitos de 
leishmaniose visceral em pacientes com HIV/AIDS internados em 
hospitais de referência de Pernambuco, Brasil. De 14 pacientes elegíveis 
com citopenias e/ou febre de etiologia indefinida, com indicações de 
mielograma, foram incluídos dez. Para o diagnóstico, foram empregados 
os seguintes exames: pesquisa de Leishmania em aspirado de medula 
óssea, DAT, IFI, rK39, PCR e a KAtex. Cinco dos dez pacientes foram 
diagnosticados com co-infecção. Entre os cinco co-infectados, o DAT foi 
positivo em todos, a pesquisa de Leishmania foi positiva em quatro, assim 
como o KAtex, o rK39 em três, a IFI em dois e a PCR positiva em apenas 
um. Esta série de casos foi a primeira realizada no Brasil utilizando esse 
conjunto de exames para detecção de co-infecção, no entanto, ainda não 
há consenso quanto aos exames mais adequados a serem aplicados para 
screening e acompanhamento desse grupo de pacientes.
ACKNOWLEDGEMENTS
Funding: This work was supported by grant APQ-1284-4.01/08 
from the FACEPE (Foundation for Science and Technology of the State 
of Pernambuco) and PIBIC/CNPq (National Counsel of Technological 
and Scientific Development, Institutional Program for Scientific Initiation 
Scholarships), proposal contract No.: 109169/2009-3. 
REFERENCES
 1.  Alexandrino-de-Oliveira P, Santos-Oliveira JR, Dorval ME, Da-Costa FC, Pereira 
GR, da Cunha RV, et al. HIV/AIDS-associated visceral leishmaniasis in patients from 
an endemic area in Central-west Brazil. Mem Inst Oswaldo Cruz. 2010;105:692-7.
 2.  Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, et al. The 
relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol 
Rev. 2008;21:334-59. 
 3.  Alvar J, Cañavate C, Molina R, Moreno J, Nieto J. Canine leishmaniasis. Adv Parasitol. 
2004;57:1-88.
 4.  Assis TS, Braga AS, Pedras MJ, Oliveira E, Barral A, de Siqueira IC, et al. Multi-
centric prospective evaluation of rk39 rapid test and direct agglutination test for 
the diagnosis of visceral leishmaniasis in Brazil. Trans R Soc Trop Med Hyg. 
2011;105:81-5.
 5.  Attar ZJ, Chance ML, El-Safi S, Carney J, Azazy A, El-Hadi M, et al. Latex 
agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta 
Trop. 2001;78:11-6.
 6.  Carranza-Tamayo CO, Assis TSM, Neri ATB, Cupolillo E, Rabello A, Romero GAS. 
Prevalence of Leishmania infection in adult HIV/AIDS patients treated in a tertiary-
level care center in Brasilia, Federal District, Brazil. Trans R Soc Trop Med Hyg. 
2009;103:743-8.
 7.  Centers for Disease Control. 1993 revised classification system for HIV infection 
and expanded surveillance case definition for AIDS among adolescents and adults. 
MMWR Recomm Rep. 1992;41(RR-17):1-19.
 8.  Chang MR, Taira CL, Paniago AMM, Taira DL, Cunha RV, Wanke B. Study of 30 
cases of histoplasmosis observed in the Mato Grosso do Sul State, Brazil. Rev Inst 
Med Trop Sao Paulo. 2007;49:37-9.
 9.  Chappuis F, Rijal S, Singh R, Acharya P, Karki BMS, Das ML, et al. Prospective 
evaluation and comparison of the direct agglutination test and an rK39-antigen-based 
dipstick test for the diagnosis of suspected kala-azar in Nepal. Trop Med Int Health. 
2003;8:277-85.
 10.  Daher EF, Fonseca PP, Gerhard ES, Silva Leitão TMJ, Silva Júnior GB. Clinical and 
epidemiological features of visceral leishmaniasis and co-infection in 15 patients 
from Brazil. J Parasitol. 2009;95:652-5.
 11.  Dantas-Torres F, Brandão-Filho SP. Expansão geográfica da leishmaniose visceral 
no Estado de Pernambuco. Rev Soc Bras Med Trop. 2006;39:352-6.
 12.  Ghatei MA, Hatam GR, Hossini MH, Sarkari B. Performance of latex agglutination 
test (KAtex) in diagnosis of visceral leishmaniasis in Iran. Iran J Immunol. 
2009;6:202-7.
 13.  Gavgani AM, Vatan SK, Ghazanchaei A. KAtex antigen-detection test as a diagnostic 
tool for latent visceral leishmaniasis cases. Afr J Biotechnol. 2008;7:852-9.
 14.  Hailu A, Berhe N. The performance of direct agglutination tests (DAT) in the diagnosis 
of visceral leishmaniasis among Ethiopian patients with HIV co-infection. Ann Trop 
Med Parasitol. 2002;96:25-30.
 15.  Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, et al. Occurrence 
of Leishmania infantum parasitemia in asymptomatic blood donors living in an area 
of endemicity in southern France. J Clin Microbiol. 1999;37:1953-7.
CAVALCANTI, A.T.A.; MEDEIROS, Z.; LOPES, F.; ANDRADE, L.D.; FERREIRA, V.M.; MAGALHAES, V. & MIRANDA-FILHO, D.B. - Diagnosing visceral leishmaniasis and HIV/
AIDS co-infection: a case series study in Pernambuco, Brazil. Rev. Inst. Med. Trop. Sao Paulo, 54(1): 43-7, 2012. 
47
 16.  Lyons S, Veeken H, Long J. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop 
Med Int Health. 2003;8:733-9.
 17.  Maia-Elkhoury ANS, Carmo EH, Sousa-Gomes ML, Mota, E. Análise dos registros 
de leishmaniose visceral pelo método de captura-recaptura. Rev Saude Pública. 
2007;41:931-7.
 18.  Marques N, Cabral S, Sá R, Coelho F, Oliveira J, Saraiva da Cunha JG, et al. 
Leishmaniose visceral e infecção por vírus da imunodeficiência humana na era da 
terapêutica anti-retrovírica de alta eficácia. Acta Med Port. 2007;20:291-8.
 19.  Mira JA, Corzo JE, Rivero A, Macías J, De León FL, Torre-Cisneros J, et al. Frequency 
of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients 
receiving highly active antiretroviral therapy. Am J Trop Med Hyg. 2004;70:298-301.
 20.  Molina I, Falcó V, Crespo M, Riera C, Ribera E, Curran A, et al. Efficacy of liposomal 
amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected 
patients. J Antimicrob Chemother. 2007;60:837-42.
 21.  Osman OF, Oskam L, Zijlstra EE, Kroon NC, Schoone GJ, Khalil ET, et al. Evaluation 
of PCR for diagnosis of visceral leishmaniasis. J Clin Microbiol. 1997;35:2454-7.
 22.  Pasquau F, Ena J, Sanchez R, Cuadrado JM, Amador C, Flores J, et al. Leishmaniasis 
as an opportunistic infection in HIV-infected patients: determinants of relapse and 
mortality in a collaborative study of 228 episodes in a Mediterreanean region. Euro 
J Clin Microbiol Infect Dis. 2005;24:411-8.
 23.  Pastore RD, Chadburn A, Kripas C, Schattner EJ. Novel association of 
haemophagocytic syndrome with Kaposi’s sarcoma-associated herpesvirus-related 
primary effusion lymphoma, Br J Haematol. 2000;111:1112-5.
 24.  Pintado V, López-Vélez R. HIV-associated visceral leishmaniasis. Clin Microbiol 
Infect. 2001;7:291-300.
 25.  Rabello A, Orsini M, Disch J. Leishmania/HIV co-infection in Brazil: an appraisal. 
Ann Trop Med Parasitol. 2003;97(Suppl 1):17-28.
 26.  Reyes Corcho A, Díaz Jidy M, Pérez Rodriguez A, Bouza Jiménez Y, Bouza Jiménez 
Y. Factores asociados con la presnecia de tuberculosis en pacientes con el syndrome 
de inmunodeficiencia adquirida en Cuba. Rev Panam Salud Publica. 2004;15: 341-7.
 27.  Riera C, Fisa R, Lopez P, Ribera E, Carrió J, Falcó V, et al. Evaluation of a latex 
agglutination test (KAtex) for detection of Leishmania antigen in urine of patients 
with HIV-Leishmania co-infection: value in diagnosis and post-treatment follow up. 
Eur J Clin Microbiol Infect Dis. 2004;23:899-904.
 28.  Roselino AM, Chociay MF, Costa RS, Machado AA, Figueiredo JFC. L. (L.) chagasi 
in AIDS and visceral leishmaniasis (kala-azar) co-infection. Rev Inst Med Trop Sao 
Paulo. 2008;50:251-4.
 29.  Sinha PK, Pandey K, Bhattacharya SK. Diagnosis & management of leishmania/
HIV co-infection. Indian J Med Res. 2005;121:407-14.
 30.  Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal 
amphotericin B for visceral leishmaniasis in India. N Engl J Med. 2010;362:504-12.
 31.  Sundar S, Reed SG, Singh VP, Kumar PC, Murray HW. Rapid accurate field diagnosis 
of Indian visceral leishmaniasis. Lancet. 1998;351:563-5.
 32.  Ter Horst R, Collin SM, Ritmeíjer K, Bogale A, Davidson RN. Concordant HIV 
infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral 
treatment and other factors on outcome. Clin Infect Dis. 2008;46:1702-9.
 33.  Ter Horst R, Tefera T, Assefa G, Ebrahim AZ, Davidson RN, Ritmeijer K. Field 
evaluation of rK39 test and direct agglutination test for diagnosis of visceral 
leishmaniasis in a population with high prevalence of human immunodeficiency 
virus in Ethiopia. Am J Trop Med Hyg. 2009;80:929-34.
 34.  Vilaplana C, Blanco S, Domínguez J, Giménez M, Ausina V, Muñoz C. Noninvasive 
method for diagnosis of visceral leishmaniasis by a latex agglutination test for 
detection of antigens in urine samples. J Clin Microbiol. 2004;42:1853-4.
 35.  Zijlstra EE, Ali MS, El-Hassan AM, El-Toum IA, Satti M, Ghalib HW, et al. Kala-
azar: a comparative study of parasitological methods and the direct agglutination test 
in diagnosis. Trans R Soc Trop Med Hyg. 1992;86:505-7.
 Received: 24 July 2011
 Accepted: 14 December 2011
